<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/C90D7E98-8734-42EC-8E32-A325A691A3C3/chart/price-vs-fair-value?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/C90D7E98-8734-42EC-8E32-A325A691A3C3/chart/price-vs-fair-value"/></p>
<p>纳斯达克：REAL 1 年股价与公允价值</p>
<p>探索来自社区的 RealReal 公允价值并选择您的观点</p>
<p><strong>The RealReal, Inc.</strong>（纳斯达克：REAL）刚刚发布了最新的季度业绩，情况看起来乐观。收入和每股亏损均好于预期，收入为 1.65 亿美元，比预期高出 3.5%。法定亏损小于分析师预期，每股亏损为 0.10 美元。分析师通常在每次财报发布时更新他们的预测，我们可以从他们的估计中判断他们对公司的看法是否发生了变化，或者是否有新的关注点。读者会高兴地知道，我们汇总了最新的法定预测，以查看分析师在最新业绩发布后是否改变了对 RealReal 的看法。</p>
<p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前入场。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/159488957-earnings-and-revenue-growth-1-dark-2/1754836080150?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/159488957-earnings-and-revenue-growth-1-dark-2/1754836080150"/></p>
<p>纳斯达克：REAL 收入和收益增长 2025 年 8 月 10 日</p>
<p>考虑到最新的业绩，RealReal 的八位分析师目前的共识是 2025 年的收入为 6.726 亿美元。这将反映出过去 12 个月收入的 5.6% 的适度增长。RealReal 也预计将实现盈利，法定每股收益为 0.26 美元。在这份最新报告之前，市场共识预期收入为 6.579 亿美元，每股亏损为 0.12 美元。因此，我们可以看到，在最新业绩发布后，预期有了明显的上调，预计适度的收入增长将使盈利提前于之前的预测。</p>
<p>查看我们对 RealReal 的最新分析</p>
<p>尽管分析师上调了他们的收益预期，但共识价格目标仍保持在 8.91 美元，这表明预测的表现对公司估值没有长期影响。不过，还有另一种看待价格目标的方法，那就是查看分析师提出的价格目标范围，因为广泛的估计范围可能表明对业务可能结果的不同看法。目前，最乐观的分析师将 RealReal 的每股价值定为 15.00 美元，而最悲观的分析师则定为 2.40 美元。正如您所看到的，估计范围很广，最低估值不到最乐观估计的一半，这表明分析师对该业务的表现有着强烈的分歧。因此，基于共识价格目标做出决策可能不是一个好主意，毕竟这只是这一广泛估计范围的平均值。</p>
<p>现在从更大的视角来看，我们可以通过将这些预测与过去的表现和行业增长预期进行比较来理解这些预测。根据分析师的说法，到 2025 年底的这一时期将保持相似的趋势，预计收入将以 12% 的年化速度增长。这与过去五年的 13% 的年增长率相符。与更广泛的行业相比，分析师的估计（总体）表明，行业收入年增长率为 5.7%。因此，尽管预计 RealReal 将保持其收入增长率，但其增长速度显然将快于更广泛的行业。</p>
<h2>结论</h2>
<p>最重要的是要认识到，分析师对该业务前景的信心发生了明显的变化，预计 RealReal 将在明年实现盈利。令人欣慰的是，他们还上调了收入预期，并预计其增长速度将快于更广泛的行业。共识价格目标保持在 8.91 美元，最新的估计不足以对其价格目标产生影响。</p>
<p>考虑到这一点，我们不应过于急于对 RealReal 得出结论。长期的盈利能力远比明年的利润重要。在 Simply Wall St，我们有一系列到 2027 年的 RealReal 分析师估计，您可以在我们的平台上免费查看。</p>
<p>此外，您还应该了解我们发现的关于 RealReal 的 <strong>一个警告信号</strong>。</p>

REAL

<p>分析师在 The RealReal, Inc.（纳斯达克代码：REAL）最近公布季度业绩后更新了他们的预估，该业绩显示出超出预期的收入为 1.65 亿美元，且每股亏损小于预期，为 0.10 美元。2025 年的共识预测现在预计收入为 6.726 亿美元，每股收益为 0.26 美元，表明盈利能力的转变。尽管进行了上调，但共识目标价仍保持不变，为 8.91 美元，反映出分析师的预估范围广泛，从 2.40 美元到 15.00 美元不等。总体而言，分析师预计 RealReal 的增长速度将快于更广泛的行业，预计年收入增长为 12%</p>

<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/C90D7E98-8734-42EC-8E32-A325A691A3C3/chart/price-vs-fair-value" alt="" original-src="https://images.simplywall.st/company/C90D7E98-8734-42EC-8E32-A325A691A3C3/chart/price-vs-fair-value"/></p>
<p>NasdaqGS:REAL 1 Year Share Price vs Fair Value</p>
<div class="lb-trans"><p>纳斯达克：REAL 1 年股价与公允价值</p>
</div><p>Explore RealReal's Fair Values from the Community and select yours</p>
<div class="lb-trans"><p>探索来自社区的 RealReal 公允价值并选择您的观点</p>
</div><p><strong>The RealReal, Inc.</strong> (NASDAQ:REAL) just released its latest quarterly results and things are looking bullish. Revenues and losses per share were both better than expected, with revenues of US$165m leading estimates by 3.5%. Statutory losses were smaller than the analystsexpected, coming in at US$0.10 per share. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on RealReal after the latest results.</p>
<div class="lb-trans"><p><strong>The RealReal, Inc.</strong>（纳斯达克：REAL）刚刚发布了最新的季度业绩，情况看起来乐观。收入和每股亏损均好于预期，收入为 1.65 亿美元，比预期高出 3.5%。法定亏损小于分析师预期，每股亏损为 0.10 美元。分析师通常在每次财报发布时更新他们的预测，我们可以从他们的估计中判断他们对公司的看法是否发生了变化，或者是否有新的关注点。读者会高兴地知道，我们汇总了最新的法定预测，以查看分析师在最新业绩发布后是否改变了对 RealReal 的看法。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前入场。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/159488957-earnings-and-revenue-growth-1-dark-2/1754836080150" alt="" original-src="https://images.simplywall.st/asset/chart/159488957-earnings-and-revenue-growth-1-dark-2/1754836080150"/></p>
<p>NasdaqGS:REAL Earnings and Revenue Growth August 10th 2025</p>
<div class="lb-trans"><p>纳斯达克：REAL 收入和收益增长 2025 年 8 月 10 日</p>
</div><p>Taking into account the latest results, the current consensus from RealReal's eight analysts is for revenues of US$672.6m in 2025. This would reflect an okay 5.6% increase on its revenue over the past 12 months. RealReal is also expected to turn profitable, with statutory earnings of US$0.26 per share. Before this latest report, the consensus had been expecting revenues of US$657.9m and US$0.12 per share in losses. So we can see there's been a pretty clear upgrade to expectations following the latest results, with a modest lift to revenues expected to lead to profitability earlier than previously forecast.</p>
<div class="lb-trans"><p>考虑到最新的业绩，RealReal 的八位分析师目前的共识是 2025 年的收入为 6.726 亿美元。这将反映出过去 12 个月收入的 5.6% 的适度增长。RealReal 也预计将实现盈利，法定每股收益为 0.26 美元。在这份最新报告之前，市场共识预期收入为 6.579 亿美元，每股亏损为 0.12 美元。因此，我们可以看到，在最新业绩发布后，预期有了明显的上调，预计适度的收入增长将使盈利提前于之前的预测。</p>
</div><p>View our latest analysis for RealReal</p>
<div class="lb-trans"><p>查看我们对 RealReal 的最新分析</p>
</div><p>Althoughthe analysts have upgraded their earnings estimates, there was no change to the consensus price target of US$8.91, suggesting that the forecast performance does not have a long term impact on the company's valuation. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. Currently, the most bullish analyst values RealReal at US$15.00 per share, while the most bearish prices it at US$2.40. As you can see the range of estimates is wide, with the lowest valuation coming in at less than half the most bullish estimate, suggesting there are some strongly diverging views on how analysts think this business will perform. As a result it might not be a great idea to make decisions based on the consensus price target, which is after all just an average of this wide range of estimates.</p>
<div class="lb-trans"><p>尽管分析师上调了他们的收益预期，但共识价格目标仍保持在 8.91 美元，这表明预测的表现对公司估值没有长期影响。不过，还有另一种看待价格目标的方法，那就是查看分析师提出的价格目标范围，因为广泛的估计范围可能表明对业务可能结果的不同看法。目前，最乐观的分析师将 RealReal 的每股价值定为 15.00 美元，而最悲观的分析师则定为 2.40 美元。正如您所看到的，估计范围很广，最低估值不到最乐观估计的一半，这表明分析师对该业务的表现有着强烈的分歧。因此，基于共识价格目标做出决策可能不是一个好主意，毕竟这只是这一广泛估计范围的平均值。</p>
</div><p>Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. The period to the end of 2025 brings more of the same, according to the analysts, with revenue forecast to display 12% growth on an annualised basis. That is in line with its 13% annual growth over the past five years. Compare this with the broader industry, which analyst estimates (in aggregate) suggest will see revenues grow 5.7% annually. So although RealReal is expected to maintain its revenue growth rate, it's definitely expected to grow faster than the wider industry.</p>
<div class="lb-trans"><p>现在从更大的视角来看，我们可以通过将这些预测与过去的表现和行业增长预期进行比较来理解这些预测。根据分析师的说法，到 2025 年底的这一时期将保持相似的趋势，预计收入将以 12% 的年化速度增长。这与过去五年的 13% 的年增长率相符。与更广泛的行业相比，分析师的估计（总体）表明，行业收入年增长率为 5.7%。因此，尽管预计 RealReal 将保持其收入增长率，但其增长速度显然将快于更广泛的行业。</p>
</div><h2>The Bottom Line</h2>
<div class="lb-trans"><h2>结论</h2>
</div><p>The most important thing to take away is that there's been a clear step-change in belief around the business' prospects, with the analysts now expecting RealReal to become profitable next year. Happily, they also upgraded their revenue estimates, and are forecasting them to grow faster than the wider industry. The consensus price target held steady at US$8.91, with the latest estimates not enough to have an impact on their price targets.</p>
<div class="lb-trans"><p>最重要的是要认识到，分析师对该业务前景的信心发生了明显的变化，预计 RealReal 将在明年实现盈利。令人欣慰的是，他们还上调了收入预期，并预计其增长速度将快于更广泛的行业。共识价格目标保持在 8.91 美元，最新的估计不足以对其价格目标产生影响。</p>
</div><p>With that in mind, we wouldn't be too quick to come to a conclusion on RealReal. Long-term earnings power is much more important than next year's profits. At Simply Wall St, we have a full range of analyst estimates for RealReal going out to 2027, and you can see them free on our platform here..</p>
<div class="lb-trans"><p>考虑到这一点，我们不应过于急于对 RealReal 得出结论。长期的盈利能力远比明年的利润重要。在 Simply Wall St，我们有一系列到 2027 年的 RealReal 分析师估计，您可以在我们的平台上免费查看。</p>
</div><p>Plus, you should also learn about the <strong>1 warning sign</strong> we've spotted with RealReal .</p>
<div class="lb-trans"><p>此外，您还应该了解我们发现的关于 RealReal 的 <strong>一个警告信号</strong>。</p>
</div>

分析师在 The RealReal, Inc.（纳斯达克股票代码：REAL）公布第二季度业绩后更新了他们的预测